Skip to main content
OpenTrials

Clinical trial condition

Recurrent Platinum-Sensitive Ovarian High Grade Serous Adenocarcinoma

Explore clinical trials studying Recurrent Platinum-Sensitive Ovarian High Grade Serous Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Platinum-Sensitive Ovarian High Grade Serous Adenocarcinoma trial results

Not Yet Recruiting

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

NCT07504588

Conditions
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Platinum-Sensitive Fallopian Tube High Grade Serous Adenocarcinoma, Recurrent Platinum-Sensitive Ovarian High Grade Endometrioid Adenocarcinoma, +3 more
Locations

Not specified

View Trial Details

Related conditions